NeoStem Inc Stock price Nyse
Equities
NBS
US6406503051
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | 0.00% |
Mar. 21 | Sector Update: Health Care Stocks Higher in Late Afternoon Trading | MT |
Mar. 21 | Sector Update: Health Care Stocks Higher in Afternoon Trading | MT |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 25.92M |
---|---|---|---|---|---|
Net income 2024 * | -25M | Net income 2025 * | -30M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.01
x | P/E ratio 2025 * |
-1.16
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 81% |
Latest transcript on NeoStem Inc
1st Jan change | Capi. | |
---|---|---|
+9.30% | 46.03B | |
+52.73% | 44.55B | |
+7.15% | 40.8B | |
-8.78% | 28.25B | |
+18.68% | 27.71B | |
-21.92% | 18.82B | |
+14.62% | 13.91B | |
+31.85% | 12.43B | |
-8.77% | 11.06B |
- Stock
- Equities
- Stock Lisata Therapeutics, Inc.
- Stock NeoStem Inc - Nyse